Janux Therapeutics Inc.

AI Score

0

Unlock

46.83
1.48 (3.26%)
At close: Jan 15, 2025, 10:24 AM

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19
Revenue 8.08M 8.61M 3.64M n/a n/a
Cost of Revenue 1.96M 841.00K 113.00K 13.00K 6.00K
Gross Profit 6.13M 7.77M 3.52M -13.00K -6.00K
Operating Income -72.98M -67.09M -32.93M -4.84M -3.77M
Interest Income 14.69M 4.03M 257.00K 206.00K 233.00K
Pretax Income -58.29M -63.06M -32.67M -6.78M -4.00M
Net Income -58.29M -54.15M -32.56M -5.25M -4.24M
Selling & General & Admin 26.14M 22.26M 10.33M 1.80M 772.00K
Research & Development 54.92M 53.44M 26.24M 3.04M 3.00M
Other Expenses n/a 4.03M 257.00K -1.74M n/a
Operating Expenses 81.06M 75.70M 36.57M 4.84M 3.77M
Interest Expense n/a 4.03M n/a 206.00K 233.00K
Selling & Marketing Expenses n/a n/a n/a n/a n/a
Cost & Expenses 81.06M 75.70M 36.57M 4.84M 3.77M
Income Tax n/a -8.90M -113.00K -1.53M 233.00K
Shares Outstanding (Basic) 44.02M 41.47M 41.24M 41.61M 41.61M
Shares Outstanding (Diluted) 44.02M 41.47M 41.24M 41.61M 41.61M
EPS (Basic) -1.32 -1.31 -0.79 -0.13 -0.1
EPS (Diluted) -1.32 -1.31 -0.79 -0.13 -0.1
EBITDA -71.02M -66.25M -32.82M -4.83M -3.77M
Depreciation & Amortization 1.96M 841.00K 113.00K 13.00K 6.00K